Re-Sensitizing Cancer Cells to Anticancer Drugs

Tech ID: 27249 / UC Case 2016-496-0

Abstract

Researchers at the University of California, Davis have discovered a new class of ROR-γ inhibitors which can reduce and reverse cancer cell resistance to anticancer drugs.

Full Description

The use of concurrent cancer therapies (chemotherapy, radiation therapy, hormone deprivation therapy, etc.) is typical in cancer treatment due to the development of drug-resistance and mutations in cancer cells. As a result, there is a constant need for new drugs and treatments to treat cancer. There is a need, as future therapies are developed, to maintain cancer cell sensitivity to the anticancer drugs.

Researchers at the University of California, Davis have discovered ROR-γ inhibitors which can reduce and even reverse cancer cell resistance to anticancer drugs. These phenyl-sulfonamide derivatives can be administered in combination with existing anticancer drugs. The derivatives are effective against a wide range of cancers, allowing for different delivery compositions and delivery mechanisms into the body, making it suitable for pharmaceutical use in both animals and people. The inhibitors have been synthesized and verified in vitro in lung, breast, liver, ovarian, endometrial, colon, lymph, glial and other cancer cell types. They have also been verified in vivo in a xenograft mouse model with human cancer cells.

Applications

  • Cancer

Features/Benefits

  • Can be used concurrently with existing cancer therapies
  • Re-sensitize and/or reduce cancer-cell resistance to current treatment/drug
  • Multiple delivery compositions, allowing for optimal dosage
  • Multiple routes of administration, allowing for optimal delivery into the body

Related Materials

Patent Status

Country Type Number Dated Case
Patent Cooperation Treaty Reference for National Filings 2017127442 07/27/2017 2016-496
 

Patent Pending

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Chen, Hongwu
  • Wang, Junjian (Jack)
  • Zou, June X.

Other Information

Keywords

ROR-gamma inhibitor, reverse cancer cell resistance, reduce cancer cell resistance, re-sensitize

Categorized As

Additional Technologies by these Inventors